CUSIP 558868105COMMDGLQ4 2025
58 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Baker Bros. Advisors LP | 2.14M | $1.25B |
| 2 | Rtw Investments, LP | 1.99M | $1.16B |
| 3 | Vanguard Group Inc | 1.81M | $1.05B |
| 4 | Avoro Capital Advisors LLC | 1.81M | $1.05B |
| 5 | Paulson & Co. Inc. | 1.71M | $994.36M |
| 6 | Blackrock, Inc. | 1.64M | $957.80M |
| 7 | Janus Henderson Group PLC | 1.58M | $918.20M |
| 8 | State Street Corp | 583.0K | $339.51M |
| 9 | Wellington Management Group LLP |
| 4 | Dec 12, 2025 | Paul A Friedman, M.D. | 13D/A | 7.8% | — | SEC |
| 5 | Dec 12, 2025 | Rebecca Taub, M.D. | 13D/A | 7.8% | — | SEC |
| 6 | Dec 12, 2025 | Paul A Friedman, M.D. | 13D/A | 7.8% | — | SEC |
| 7 | Nov 14, 2025 | Janus Henderson Group PLC | 13G/A | 8.3% | 1.84M | SEC |
| 8 | Aug 14, 2025 | Janus Henderson Group PLC | 13G/A | 9.9% | 2.19M | SEC |
| 9 | May 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.0% | 2.21M | SEC |
| 10 | Feb 14, 2025 | Janus Henderson Group PLC | 13G/A | 10.1% | 2.21M | SEC |
See the full Schedule 13D/13G history for Madrigal Pharmaceuticals Inc.
Unlock full history| 461.4K |
| $268.69M |
| 10 | Geode Capital Management, LLC | 451.7K | $263.11M |